4-Bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-3,6-dihydro-7H-imidazo[4,5-h]isoquinoline-7,9(8H)-dione

Catalog No. :
ACLQYG159
CAS No. :
851659-01-3
Molecular Formula :
C19H15BrN4O4
Molecular Weight :
443.26

IUPAC Name:4-bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-3,6-dihydro-7H-imidazo[4,5-h]isoquinoline-7,9(8H)-dione

4-Bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-3,6-dihydro-7H-imidazo[4,5-h]isoquinoline-7,9(8H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$1376.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-3,6-dihydro-7H-imidazo[4,5-h]isoquinoline-7,9(8H)-dione
IUPAC Name4-bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-3,6-dihydro-7H-imidazo[4,5-h]isoquinoline-7,9(8H)-dione
MDL No.MFCD32632810
Molecular FormulaC19H15BrN4O4
Molecular Weight443.26
SMILESO=C(C(C)(C)C1=C2C3=C(NC(C4=CC=C(C)C([N+]([O-])=O)=C4)=N3)C(Br)=C1)NC2=O
InChI KeyWSOKCMVNHOQAHA-UHFFFAOYSA-N
Synonym4-Bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-3H-imidazo[4,5-h]isoquinoline-7,9(6H,8H)-dione;3H-Imidazo[4,5-h]isoquinoline-7,9(6H,8H)-dione, 4-bromo-6,6-dimethyl-2-(4-methyl-3-nitrophenyl)-
CAS No.851659-01-3

Synthetic Route by SureRoute

1. ACLQYG159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACANTI269 route compound structure diagram
    ACANTI26931680-07-6 In Stock
  4. Then
  5. ACLQYG159 route product structure diagram
    ACLQYG159851659-01-3
Inquiry

2. ACLQYG159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJLAZ810 route compound structure diagram
    ACJLAZ81096-98-0 In Stock
  4. Then
  5. ACLQYG159 route product structure diagram
    ACLQYG159851659-01-3
Inquiry

Comments (0)